Business Wire

WorldQuant Completes Inaugural International Quant Championship

Del

WorldQuant, the global quantitative asset management firm, announced the completion of its inaugural International Quant Championship, a competition designed to simulate the best algorithms with over 11,000 participants from more than 1,000 universities across 80 countries. The 47 finalists traveled from 15 countries for the ultimate competition in Singapore, following regional finals where over 500 teams competed in Bangkok, Beijing, Hanoi, Moscow, Mumbai, Seoul, Singapore and Taipei.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180928005571/en/

(Photo: Business Wire)

(Photo: Business Wire)

“The scale and success of our competition cements our philosophy that talent is distributed globally and there remains an untapped pool of extremely smart data scientists seeking professional opportunities that can be delivered virtually. Our vision remains to further scale WorldQuant’s virtual network to bring opportunity to any individual with the interest and ability to put their expertise to use,” said Igor Tulchinsky, Founder, Chairman and CEO of WorldQuant.

The International Quant Championship builds on the 20 competitions that the WorldQuant Virtual Research Center has hosted over the past five years to uncover talent globally, foster interest in quantitative finance and allow participants to compete with top quantitative minds. Participants come from various disciplines, including computer science, engineering, physics, finance, business administration and mechanics, and are evaluated on a range of skills, including the use of operators and datasets and the understanding, selection and execution of high-quality algorithms.

“Academic theory does not directly teach the discipline of quantitative finance, so it is up to industry to build up the skills required by individuals to become successful quants and creating practical algorithm simulations is an essential part of that process. We are also pleased that over a quarter of our International Quant Championship contestants were women, including the winning team of three Russian women living in France,” said Nitish Maini, General Manager of WorldQuant Virtual Research Center.

WorldQuant Virtual Research Center has more than 70,000 users from 180 countries and over 2,000 universities who are given the opportunity to learn about quantitative finance, build financial models, participate in global competitions and be considered for research consultant positions. WorldQuant has discovered over 1,000 consultants through the Virtual Research Center and users have collectively run over 93 million simulations on the Virtual Research Center’s online platform.

About WorldQuant

WorldQuant is a global quantitative asset management firm that was founded in 2007 by Igor Tulchinsky and has over $7 billion in assets under management. The firm has more than 25 offices in 15 countries and over 700 employees and 1,000 consultants. WorldQuant develops and deploys systematic investment strategies across a variety of asset classes in global markets, utilizing a proprietary research platform and investment process. For more information on WorldQuant’s culture and philosophy, please visit www.WeAreWorldQuant.com.

Contact information

Media contacts
Beatriz Garcia / Christina Tilt
worldquant@brunswickgroup.com
+1 212 333 3810

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

The O-RAN Alliance Announces New Board Members11.12.2018 14:00Pressemelding

The O-RAN Alliance announced today that Reliance Jio, TIM, and Verizon have joined the O-RAN board. “It’s encouraging to see the O-RAN Alliance off to such a strong start and gaining momentum as we welcome three new board members. It’s important that the wireless industry continues to come together to drive forward O-RAN’s goals for open networking, software, and virtualization in global wireless networks especially as 5G is closer than ever,” said Andre Fuetsch, Chairman of the O-RAN Alliance, President-AT&T Labs and CTO of AT&T. “This is a great opportunity for the Service Provider Industry as network, services and applications leverage cloud native platforms and the right time to fundamentally transform the RAN infrastructure and platforms. We look forward to working closely with the O-RAN Alliance in the acceleration and adoption of open, intelligent, and programmable RAN architectures that can clearly disrupt the building blocks of 5G and beyond,” said Mathew Oommen, President, Re

Seoul Semiconductor Wins Patent Litigation against Everlight in Germany and Is Awarded Statutory Litigation Costs11.12.2018 14:00Pressemelding

Seoul Semiconductor Co., Ltd. (KOSDAQ:046890) (“Seoul”), a leading global innovator of LED products and technology, announced that it won a patent litigation against Everlight Electronics Co., Ltd. (“Everlight”) in Germany. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181211005233/en/ Seoul Semiconductor's Headquarters in Korea (Photo: Business Wire) The patent involved in this litigation relates to an LED package structure for thermal dissipation. Everlight purchased this patent from a U.S. company in 2017, and subsequently brought a patent lawsuit against Seoul in the Manheim Court of Germany. In December 2018, however, the Manheim Court ruled in favor of Seoul and ordered that Everlight, as the losing party, should bear the statutory costs of the court proceeding. In the United Kingdom, Seoul had already won a patent litigation against Everlight earlier this year. At that time, the UK Patent Court also ordered that Ever

Zodiac Appoints Derek Harrar CEO11.12.2018 14:00Pressemelding

Zodiac, a software vendor serving video service providers, announced today it has appointed Derek Harrar to serve as the Company’s Chief Executive Officer, effective immediately. Mr. Harrar has been on Zodiac’s board of directors since 2015, having being appointed at the time of One Equity Partners’ investment in the Company. “Derek’s considerable video industry operational and technology experience, rigorous execution and creativity are exactly what Zodiac needs for its next stage of growth, complementing the team we have put in place since our original investment,” said Andrew Dunn, Managing Director at One Equity Partners. Zodiac’s historic focus has been engineering software solutions for major video service providers in North America. This software experience, spanning a broad range of video technology permutations, is unique in the video distribution industry. More recently, Zodiac productized its carrier-grade cloud and client platform, enabling rapid and flexible deployment at

Quotient Sciences Conducts Integrated Translational Pharmaceutics® Program in U.S. with Druggability Technologies11.12.2018 13:00Pressemelding

Quotient Sciences, a leading drug development services organization, and Druggability Technologies (DRGT), a specialty pharmaceutical company, announced a collaboration today to utilize Quotient’s integrated Translational Pharmaceutics® platform to advance the development of DRGT-46, a novel, fast-acting formulation of celecoxib using proprietary super-API compositions developed by DRGT. This will be Quotient’s first Translational Pharmaceutics program delivered from its U.S. operating facilities. Within the program of work, DRGT is accessing Quotient’s unique Translational Pharmaceutics platform. This involves the development of amorphous spray-dried formulations and GMP clinical trial manufacturing in Philadelphia followed by clinical dosing and taste assessment at Quotient’s clinical pharmacology unit in Miami. The program is fully adaptive, which will enable DRGT to optimize the drug product in response to emerging clinical data. Quotient will then seamlessly scale up the selected

The Brightline Initiative Announces Strategic Partnership with NetEase11.12.2018 13:00Pressemelding

The Brightline Initiative announced today that NetEase (网易) joined its coalition as first founding member from the Asia region to help address the growing challenges of strategy implementation leveraging on insight and learnings from Chinese technology companies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181211005409/en/ Brightline Initiative Announces Strategic Partnership with NetEase (Photo: Business Wire) Launched in early 2017, the Brightline™ Initiative is a coalition, led by the Project Management Institute together with leading global organizations, dedicated to helping executives bridge the expensive and unproductive gap between strategy design and delivery. Brightline focuses its work on three key areas: Thought and Practice Leadership, Networking and Capability Building. NetEase Hangzhou Research Institute Chief Executive Chen Gang said, “Historically NetEase has been paying close attention on strategy design

AMRA Receives U.S. FDA Clearance for AMRA® Profiler, a Magnetic Resonance Diagnostic Software Application Enabling Non-Invasive Evaluation of Body Composition11.12.2018 11:28Pressemelding

AMRA Medical (“AMRA”), the international leader in body composition analysis, announced today that it has received FDA clearance for AMRA® Profiler, now available for use in a clinical setting in the US. AMRA® Profiler is indicated for use as a magnetic resonance (MR) diagnostic device for non-invasive fat and muscle evaluation that enables the generation, display and review of MR-based body composition measurements. AMRA is the first in the world to transform MR-images from a 6-minute whole-body MRI scan into 3D-volumetric fat and muscle measurements, enabling outstanding accuracy and precision when assessing volume and distribution of fat and muscles, as well as metabolic status. “We are delighted with the FDA’s decision. The challenges facing healthcare systems across the world are well-documented. Cost constraints, together with societal issues such as obesity and an aging population, are putting hospitals and private clinics under increasing pressure,” stated Eric Converse, CEO of